• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Disclosed is a new class of antitumor glycoside antibiotics of the formula (IA): <IMAGE> (IA) wherein R is hydrogen or hydroxy; and X is <IMAGE> These compounds are prepared, using novel intermediates, by condensing the appropriate aglycone and amino-deoxy sugar to form the alpha -glycosidic linkage.
    公开号:SU797583A3
    申请号:SU792778651
    申请日:1979-06-18
    公开日:1981-01-15
    发明作者:Кассинелли Джузеппе；Аркамоне Федерико；Ди Марко Аурелио
    申请人:Сочиета Фармасьютичи, Италиа С.П.А.(Фирма)；
    IPC主号:
    专利说明:

    This invention relates to a process for the preparation of new glycosides with valuable pharmacological properties. The purpose of the invention is to obtain new useful compounds expanding the arsenal of means of action on a living organism is achieved by synthesizing the latter based on the known reactions of interaction of daunomycin analogues with a solution of bromine in chloroform followed by treatment with hydrobromic acid in acetone and hydrolysis General formula II. . HjCO V «p OR where k is the hydroxy group ,. and R, - means h HjCO - t is that 4 -0-methyl-daunomycin hydrochloride or 4 -epi, -4-0 methyl daunomycin hydrochloride, dissolved in a mixture of methyl alcohol and anhydrous dioxam, is subjected to interaction for 1 -2 hours at 8-10 ° C with a solution of bromine in chloroform with obtaining, respectively, 14-bromo-4-O-methyl-daunomycin and 14-bromo-4-epi-4-0-methyl-daunomycin, which, after treatment 0, 25 n. The solution of hydrobromic acid in acetone for 10-15 hours at room temperature is subjected to hydrolysis at room temperature for 40-48 hours using an aqueous solution of sodium formate, followed by conversion of the 4 -0-methyl-adriamycin and 4 -epi-4 - free glycoside bases 0-methyl-adriamycin to the corresponding chlorohydrates by treatment with methanolic hydrochloric acid. The target product is known methods. Example 1. 4-0-methyl-adriamycin (1M1 80). 0.35 g of 4-.0-methyl-daunomycin hydrochloride is dissolved, in a mixture of 0.5 ml
    anhydrous methanol, 14 ml of dioxane and 0.35 ml of ethyl orthoformate and treated with 1.4 ml of a solution of 0.93 g of bromine in 10 ml of chloroform.
    The temperature is then maintained at 10 ° C for 3 hours, after which the mixture is poured into a mixture of 70 ml of ethyl ether and 35 ml of petroleum ether. The resulting red precipitate after filtration and washing several times with ethyl ether is dissolved in a mixture of 10 ml of acetone and 10 ml of a 0.25 n solution of hydrogen bromide until complete acidity is removed. The room temperature is then maintained for 15 hours, after which time bml of water is added to the mixture and the solution is extracted several times with chloroform to remove the aglycones. The aqueous phase is extracted with n-butanol cm until the ex: tracts become colorless. Evaporation of the combined organic solvent (n-butanol) extracts under vacuum to a small volume (about 6 ml) and precipitation with ethyl ether gives 0.30 g of a 14-bromine derivative. This last compound was dissolved in 7 ml of 0.25 N solution in water of hydrogen bromide and treated with 0.5 g of sodium formate in 5 ml of water. The reaction mixture is kept at room temperature with stirring for 48 hours and then added 1N. hydrochloric acid solution to provide a pH of 4. The resulting mixture is extracted with a mixture of ethyl ether and ethyl acetate to remove some lyophilic impurities.
    The aqueous phase, after pH adjusted to 7.6 with NaHCO3, is re-extracted with chloroform until the extracts become colorless. The combined chloroform extracts are dried over sodium sulfate and evaporated to a small volume (about 30 ml) under vacuum. To the resulting red solution, after its pH is adjusted to 3.5 with an anhydrous methanol solution of hydrogen chloride, ethyl ether is added with an excess, resulting in 0.20 g of methyl α-adriamycin as hydrochloride, melting point with decomposition, | oC) j3 + 259 (C 0.046 in SNZOH;
    Example 2.4 -Epi-4-0-methyl-adriamycin (iMl 79).
    4-Epi-4-0-methyl-daunomycin is hydroxylated at position 14 with bromo propane with bromine at position 14, as indicated in Example 1. According to the indicated method, 4-epi-4 -0-methyl-adriamycin is obtained in the form of an orange-red crystals, melting point 17000 with decomposition, | a; | i523 C + 252 ° C, 0.052 in methanol).
    Compounds 4 -0-methyl-adrimicin and 4-0-epi-4 -0-methyl-adriamycin, showing antimitotic activity, are useful therapeutic agents in the treatment of experimental tumors in animals.
    These compounds were tested on BDEj / C 57 B L (bhoVA) ml, which were injected with i.p. {in the groin area) doses of Yu cells per mouse ascitic leukemia, Ll210. The treatment was started in the form of injections into the groin area 1 day after the appearance of a new vaccination, the drugs were dissolved in distilled water in the form of iriocholorides. adriamycin, and therefore with its help it is very difficult to assess the advantage of new derivatives.
    The data in the table show that in two separate experiments 4 -0-methyl-adriamycin is more active than adriamycin at dosages of 4.4 and 6.6 mg / kg, this new derivative causes an increase in the lifetime from 130 and 212% while adriamycin at an optimal (non-toxic) dose of 6.6 mg / kg causes a 75% increase in lifetime.
    The higher activity of 4 -0-methyl-adriamycin compared with adriamycin in relation to the action against leukemia L 1210 is in a great deal with this.
    4-Epi-4-0-methyl-ardiamycin exhibits antitumor activity of the same order and the same magnitude as adriamycin, but has reduced toxicity.
    The presented results show that replacing the hydroxyl group at position 4 of the amino sugar with a methoxyl group increases the antitumor activity; imparting an epi-configuration to the replacement radical at position 4 leads to an overall decrease in toxicity, as can be inferred from observations of mice with vaccinated tumors.
    权利要求:
    Claims (1)
    [1]
    Claim
    The method of producing anthracycline gly
    cozides common formulas0p c-chji 35L j . I J '* on w γν * HCl l ^ CO 00n ORj 4L
    where R is an oxy group, a R ( means
    1/411 MjCO Jan uti .. snl and » 45 s -. about distinctively th c I am that 4 -0-methyl-downsmicin hydrochloride or
    4 '-epi-4-0-methyl-daunomycin hydrochloride, dissolved in a mixture of 50 methyl alcohol and anhydrous dioxane, is reacted for 1–2 hours at 8–10 ° C with a solution of bromine in chloroform to obtain, respectively, 14-bromo- 4-0-methyl-daunomycin and 14-bromo-4 1 -epi-4 1 -O-methyl-daunomycin, which after treatment with a 0.25 N solution of hydrobromic acid in acetone for 10-15 hours at room temperature are subjected to hydrolysis at room temperature for 40-48 hours using an aqueous solution of sodium formate, followed by translation of free gly the coside bases of 4 1 -0-methyl-adriamycin and 4'-epi-4'-0-methyl-adriamycin into the corresponding hydrochlorides by treatment with a methanolic hydrochloric acid solution.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU902666A3|1982-01-30|Method of preparing pleuromutiline glycoside derivatives
    IL239051A|2021-03-25|Triterpene saponins, methods of synthesis and uses thereof
    CS270585B2|1990-07-12|Method of 4-demethoxy-4-aminoanthracycline derivatives production
    SU797583A3|1981-01-15|Method of preparing anthracycline-glycosides
    IE46165B1|1983-03-09|Daunomycinone derivatives
    JP3300342B2|2002-07-08|Morpholinyl derivatives of doxorubicin and methods for their production
    US4366149A|1982-12-28|Antitumor anthracycline glycosides, their preparation, intermediates therefor, and compositions and use thereof
    US4188377A|1980-02-12|Carminomycin derivatives, their preparation and use
    SU993822A3|1983-01-30|Process for producing antracycline glycosides
    US4684629A|1987-08-04|3&#39;-deamino-3&#39;-hydroxy-4&#39;-deoxy-4&#39;-amino doxorubicin and related daunorubicin
    US4393052A|1983-07-12|Antitumor anthracycline glycosides, their preparation, intermediates therefor, and compositions and use thereof
    SU1054352A1|1983-11-15|N-glycosyl derivatives of daunorubicine having antibiotic effect
    US4322412A|1982-03-30|Anthracycline glycosides, their preparation, use and compositions thereof
    US4191755A|1980-03-04|Novel daunomycin derivatives, their aglycones and the use thereof
    SU1590045A3|1990-08-30|Method of producing glycoside
    CA1216282A|1987-01-06|Amino-14 steroid derivatives, process for theirpreparation and uses as drugs
    US4216157A|1980-08-05|Substituted antitumor anthracyclines
    HU198505B|1989-10-30|Process for producing antitumour anthracycline glycosides
    EP0071251A1|1983-02-09|Novel aminoglycosides and use thereof
    SU650507A3|1979-02-28|Method of obtaining glycoside antibiotics or their hydrochlorides
    US4146616A|1979-03-27|Antitumor compounds, their preparation and use
    CS196212B2|1980-03-31|Process for preparing anthracyclines
    SU902667A3|1982-01-30|Method of preparing desoxyanthracyclines
    IE43088B1|1980-12-17|Cardenolide glycosides and methods of making the same
    DE3905431A1|1989-09-07|4-Demethyl-4-O-|anthracycline glycosides
    同族专利:
    公开号 | 公开日
    NL7713850A|1978-06-26|
    FR2375252B1|1980-08-22|
    SE437992B|1985-03-25|
    CA1090788A|1980-12-02|
    AU3174877A|1979-06-28|
    US4183919A|1980-01-15|
    JPS6134437B2|1986-08-07|
    DK148098B|1985-03-04|
    FI63419B|1983-02-28|
    NO145163B|1981-10-19|
    AU518244B2|1981-09-24|
    AT354629B|1979-01-25|
    ATA907377A|1979-06-15|
    FI773822A|1978-06-23|
    DE2757102C2|1986-06-19|
    IE45951B1|1983-01-12|
    NZ186047A|1979-06-19|
    GR70040B|1982-07-26|
    BE862102A|1978-06-21|
    IL53635A|1981-03-31|
    YU301177A|1982-06-30|
    JPS5379851A|1978-07-14|
    IL53635D0|1978-03-10|
    SE7714464L|1978-06-23|
    GB1550879A|1979-08-22|
    NO774370L|1978-06-23|
    DK564777A|1978-06-23|
    IE45951L|1978-06-22|
    DK148098C|1985-07-29|
    DE2757102A1|1978-07-06|
    ZA777555B|1978-09-27|
    FR2375252A1|1978-07-21|
    CS198280B2|1980-05-30|
    NO145163C|1982-01-27|
    FI63419C|1983-06-10|
    HU176957B|1981-06-28|
    CH632770A5|1982-10-29|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    GB1506200A|1975-04-30|1978-04-05|Farmaceutici Italia|Glycosides|
    US3976667A|1975-06-19|1976-08-24|The Upjohn Company|Steffimycinone, 7-deoxysteffimycinone and derivatives|
    GB1511559A|1975-09-26|1978-05-24|Farmaceutici Italia|Anthracycline glycosides|US4265885A|1978-10-25|1981-05-05|Farmitalia Carlo Erba S.P.A.|Anthracyclines containing branched-chain amino-deoxy sugars|
    US4254110A|1979-02-02|1981-03-03|Farmitalia Carlo Erba S.P.A.|Pentofuranosyl anthracyclines, intermediates in and method for their preparation and compositions and use thereof|
    NL8001417A|1979-03-17|1980-09-19|Erba Farmitalia|ANTITUMORGLYCOSIDES.|
    BE883759A|1979-06-16|1980-10-01|Erba Farmitalia|ANTHRACYCLINE GLYCOSIDES|
    EP0022515B1|1979-07-04|1983-08-03|FARMITALIA CARLO ERBA S.p.A.|Anthracycline glycosides, process for their preparation and therapeutical composition containing them|
    DE3100968A1|1980-01-16|1982-01-14|Farmitalia Carlo Erba S.p.A., 20159 Milano|Anthracycline derivatives, a process for their preparation and pharmaceuticals containing these compounds|
    CA1248944A|1982-09-28|1989-01-17|Gareth J. Thomas|Anthracycline glycosides|
    WO2007075094A1|2005-12-27|2007-07-05|Instytut Biochemii I Biofizyki|New derivatives of epirubicin, their medicinal application and pharmaceuticaly acceptable forms of drugs|
    WO2007075092A1|2005-12-29|2007-07-05|Instytut Biochemii I Biofizyki|New derivatives of epirubicin, their medicinal application and pharmaceuticals acceptable forms of drugs|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    GB53454/76A|GB1550879A|1976-12-22|1976-12-22|Antitumour glycosides|
    [返回顶部]